Upgrade to SI Premium - Free Trial

Stifel Downgrades Lexicon Pharmaceuticals (LXRX) to Hold

July 29, 2019 2:02 AM
Stifel analyst Stephen Willey downgraded Lexicon Pharmaceuticals (NASDAQ: LXRX) from to Hold with a price target of $4.00 (from $10.00).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades

Next Articles